Eledon Pharmaceuticals (ELDN) Enterprise Value (2013 - 2026)
Eledon Pharmaceuticals (ELDN) posted Enterprise Value of -$111.1 million for Q1 2026, up 16.68% on a QoQ basis from -$133.3 million in Q4 2025, and up 53.96% year-over-year from -$72.2 million in Q1 2025.
Eledon Pharmaceuticals (ELDN) Enterprise Value (2013 - 2026) Analysis & Trends
Eledon Pharmaceuticals' Enterprise Value history runs 14 years deep, the most recent figure standing at -$111.1 million for Q1 2026.
- Quarterly Enterprise Value rose 53.96% year-over-year to -$111.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$111.1 million (up 53.96% YoY) and the FY2025 annual result came in at -$133.3 million, up 4.88% from the prior year.
- Enterprise Value was -$111.1 million for Q1 2026 at Eledon Pharmaceuticals, up from -$133.3 million in the prior quarter.
- Across five years, Enterprise Value topped out at -$9.2 million in Q1 2022 and bottomed at -$241.3 million in Q1 2025.
- A 5-year average of -$82.4 million and a median of -$71.4 million in 2023 frame the typical range for Enterprise Value.
- Annual changes were most pronounced in 2022 — Enterprise Value soared 90.9% — and 2023, when it slumped 675.85%.
- Eledon Pharmaceuticals' Enterprise Value stood at -$56.4 million in 2022, then grew by 9.41% to -$51.1 million in 2023, then sank by 174.31% to -$140.2 million in 2024, then rose by 4.88% to -$133.3 million in 2025, then gained by 16.68% to -$111.1 million in 2026.
- Business Quant data shows ELDN's Enterprise Value at -$111.1 million in Q1 2026, -$133.3 million in Q4 2025, and -$93.4 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -283.54 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | -61.40 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | -4.79 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -32.26 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | -7.25 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -8.75 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | -5.18 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -1.91 Bn |
| 10 | Eledon Pharmaceuticals | 5.43 Mn | -105.66 Mn | - | -111.09 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -111.09 Mn |
| Dec 31, 2025 | -133.34 Mn |
| Sep 30, 2025 | -93.40 Mn |
| Jun 30, 2025 | -107.57 Mn |
| Mar 31, 2025 | -241.29 Mn |
| Dec 31, 2024 | -140.18 Mn |
| Sep 30, 2024 | -78.19 Mn |
| Jun 30, 2024 | -83.61 Mn |
| Mar 31, 2024 | -42.86 Mn |
| Dec 31, 2023 | -51.10 Mn |
| Sep 30, 2023 | -59.61 Mn |
| Jun 30, 2023 | -71.38 Mn |
| Mar 31, 2023 | -46.50 Mn |
| Dec 31, 2022 | -56.41 Mn |
| Sep 30, 2022 | -65.89 Mn |
| Jun 30, 2022 | -9.20 Mn |
| Mar 31, 2022 | -9.20 Mn |
| Dec 31, 2021 | -9.30 Mn |
| Sep 30, 2021 | -94.04 Mn |
| Jun 30, 2021 | -101.13 Mn |